Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7476-7483

  Koelle, David M ^a,b   Frank, Jeannine M ^a,b   Johnson, Matthew L ^a   Kwok, William W ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; INTEGUMENT; KERATINOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS INFECTION;

EID: 0031849580     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7476-7483.1998     Document Type: Article

References (45)

1. Ashley, R. A., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunoblot for detecting antibodies to herpes simplex types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
2. L21 gene products of herpes simplex virus 1 are dispensable for growth in cultured cells. J. Virol. 68:2929-2936.
3. Blaho, J. A., C. Mitchell, and B, Roizman. 1994. An amino acid sequence shared by the herpes simplex virus 1 α regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylation of the UL21, UL31, UL47, and UL49 gene products. J. Biol. Chem. 269:17401-17410.
4. Bodmer, J. G., S. G. Marsh, E. D. Albert, W. F. Bodmer, R. E. Bonthrop, D. Charron, B. Dupont, H. A. Erlich, R. Fauchet, J. L. Strominger, A. Svejgaard, and P. I. Terasaki. 1997. Nomenclature for factor of the HLA system, 1996. Tissue Antigens 49:297-321.
5. Bressan, G. M., and K. K. Stanley. 1987. pUEX, a bacterial expression vector related to pEX with universal host specificity. Nucleic Acids Res. 15: 10056.
6. Cress, A., and S. J. Triezenberg. 1991. Nucleotide and deduced amino acid sequence of the gene encoding virion protein 16 of herpes simplex virus type 2. Gene 103:235-238.
7. Cunningham, A. L., and T. C. Merigan. 1984. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis. J. Immunol. 132: 197-202.
8. Doherty, D. G., D. M. Koelle, W. W. Kwok, S. Masewicz, M. E. Domeier, and G. T. Nepom. 1996. Allelic variants of MHC class II molecules can act as partial agonists of antigen specific T cell responses. Hum. Immunol. 47:149.
9. Dolan, A., F. E. Jamieson, C. Cunningham, B. C. Barnett, and D. J. McGeoch. 1998. The genome sequence of herpes simplex virus type 2. J. Virol. 72:2010-2021.
10. Elliott, G., G. Mouzakitis, and P. O'Hare. 1995. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J. Virol. 69:7932-7941.
11. Elliott, G. D., and D. M. Meredith. 1992. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J. Gen. Virol. 73:723-736.
12. Gignac, S. M., S. Brauer, B. Hane, H. Quentmeier, and H. G. Drexler. 1991. Elimination of mycoplasma from infected leukemia cell lines. Leukemia 5: 162-165.
13. Ho, M. 1990. Interferon as an agent against herpes simplex virus. J. Investig. Dermatol. 95:158S-160S.
14. Jerome, K. R., J. F. Tait, D. M. Koelle, and L. Corey. 1998. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 72:436-441.
15. Kit, S., M. Kit. H. Qavi, D. Trkula, and H. Otsuka. 1983. Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene. Biochem. Biophys. Acta 741:158-170.
16. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. 1994. Direct recovery of HSV-specific T lymphocyte clones from human recurrent HSV-2 lesions. J. Infect. Dis. 169:956-961.
17. + T-cell clones recovered from recurrent genital HSV-2 lesions. J. Virol. 68:2803-2810.
18. Koelle, D. M., M. L. Johnson, A. N. Ekstrom, P. Byers, and W. W. Kwok. 1997. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/ DQB1*0201. Hum. Immunol. 53:195-205.
19. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101:1500-1509.
20. Koelle, D. M., M. A. Tigges, R. L. Burke, F. W. Symington, S. R. Riddell, H. Abbo, and L. Corey. 1993. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J. Clin. Invest. 91:961-968.
21. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB codon 57 is a critical determinant of peptide binding and recognition. J. Exp. Med. 183:1253-1258.
22. Langenberg, A. G., R. L. Burke, S. F. Adair, R. Sekulovich, M. Tigges, C. L. Dekker, and L. Corey. 1995. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann. Intern. Med. 122:889-898.
23. Leslie, J., F. J. Rixon, and J. McLauchlan. 1996. Overexpression of the herpes simplex virus type 1 tegument protein VP22 increases its incorporation into virus particles. Virology 220:60-68.
24. Maitland, N. J., I. W. Smith, J. F. Peutherer, D. H. H. Robertson, and K. W. Jones. 1982. Restriction endonuclease analysis of DNA from genital isolates of herpes simplex virus type 2. Infect. Immun. 38:834-842.
25. Mickelson, E., A. Smith, S. McKinney, G. Anderson, and J. A. Hansen. 1993. A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA. Tissue Antigens 41:86-93.
26. Mikloska, A., and A. L. Cunningham. 1998. Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79:353-361.
27. Neophytou, P. I., B. O. Roep, S. D. Arden, E. M. Muir, G. Duinkerken, A. Kallan, R. R. de Vries, and J. C. Hutton. 1996. T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38 kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc. Natl. Acad. Sci. USA 93:2014-2018.
28. Novotny, M. J., M. L. Parish, and P. G. Spear. 1996. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity. Virology 221:1-13.
29. Para, M. F., K. M. Zezulak, A. J. Conley, M. Weinberger, K. Snitzer, and P. G. Spear. 1983. Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J. Virol. 45:1223-1227.
30. Phelan, A., G. Elliott, and P. O'Hare. 1998. Intercellular delivery of the complete P53 protein by VP22. Natl. Biotechnol. 16:440-443.
31. Preston, V. G., A. J. Davison, H. S. Marsden, M. C. Timbury, J. H. Subak-Sharpe, and N. M. Wilkie. 1978. Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate-early polypeptides. J. Virol. 28:499-517.
32. Smith, L. M., H. R. Petty, P. Parham, and H. M. McConnell. 1982. Cell surface properties of HLA antigens in Epstein-Barr virus-transformed cell lines. Proc. Natl. Acad. Sci. USA 79:608-612.
33. Spits, H., J. Borst, M. Giphart, J. Cougan, C. Terhorst, and J. E. De Vries. 1984. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299-304.
34. Spruance, S. L., and F. S. Chow. 1980. Pathogenesis of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences. J. Infect. Dis. 142:671-675.
35. Tigges, M. A., S. Leng, D. C. Johnson, and R. L. Burke. 1996. Human herpes simplex (HSV)-specific CD8+ CTL clones recognize HSV-2 infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 156:3901-3910.
36. Torseth, J. W., G. H. Cohen, R. J. Eisenberg, P. W. Berman, L. A. Lasky, C. P. Cerini, C. J. Heilman, S. Kerwar, and T, C. Merigan. 1987. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses. J. Virol. 61:1532-1539.
37. Watson, A. J., R. DeMars, I. S. Trowbridge, and F. H. Bach. 1983. Detection of a novel human class II HLA antigen. Nature 304:358-360.
38. Whitley, R. J. 1996. Herpes simplex virus, p. 2297-2342. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia. Pa.
39. Williams, M. V., and D. S. Parris. 1987. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme. Virology 156:282-292.
40. Wohlrab, F., B. K. Garrett, and B. Francke. 1982. Control of expression of the herpes simplex virus-induced deoxypyrimidine triphosphatase in cells infected with mutants of herpes simplex virus types 1 and 2 and intertypic recombinants. J. Virol. 43:935-942.
41. Yasukawa, M., A. Inatsuki, T. Horiuchi, and Y. Kobayashi. 1991. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells. J. Immunol. 146:1341-1347.
42. Yasukawa. M., and J. M. Zarling. 1984. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus induced proliferative activities exhibit herpes simplex virus type 1 and type 2 specific, or type common reactivities. J. Immunol. 133:2736-2742.
43. Yasukawa, M., and J. M. Zarling. 1985. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses. J. Immunol. 134:2679-2687.
44. Zarling, J. M., P. A. Moran, R. L. Burke, C. Pachl, P. W. Berman, and L. A. Lasky. 1986. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD-1. J. Immunol. 136:4669-4673.
45. L47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered thymidine kinase expression. J. Virol. 67:1482-1492.